Skip to main content

Advertisement

Table 2 List and frequency of grade ≥3 adverse events

From: Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer

Adverse event N (%) Grade
Dyspnea 1 (4.5) 3
Anemia 1 (4.5) 3
Back pain 1 (4.5) 3
Elevated creatinine 1 (4.5) 3
Facial edema around eyes 1 (4.5) 3
Generalized weakness 1 (4.5) 3
Hyperbilirubinemia 2 (9) 3
Hyperglycemia 1 (4.5) 3
Hypoalbuminemia 2 (9) 3
Hypocalcemia 1 (4.5) 3
Hyponatremia 1 (4.5) 3
Hypophosphatemia 1 (4.5) 3
Increased alkaline phosphatase 1 (4.5) 3
Increased lipase 1 (4.5) 3
Leukopenia 2 (9) 3
Neutrophil count decreased 1 (4.5) 3
Pleural effusion 1 (4.5) 3
Hyperbilirubinemia 1 (4.5) 4